Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Lopez

Showing results (261-270 of 285) with videos related to

Pageof 29
Sort By:
Advances in Therapy|March 15, 2023
Management of Older Patients with Head and Neck Cancer: A Comprehensive ReviewLeandro L Matos, Alvaro Sanabria, K Thomas Robbins, et al.
Archives of Pathology & Laboratory Medicine|September 12, 2019
Correlation of ROS1 Immunohistochemistry With <i>ROS1</i> Fusion Status Determined by Fluorescence In Situ HybridizationRichard S P Huang, Derek Smith, Catherine H Le, et al.
Biomedicines|October 29, 2025
First Spanish Experience with Stereotactic MR-Guided Adaptive Radiotherapy (SMART) in Borderline Resectable and Locally Advanced Pancreatic Cancer: A Prospective StudyDaniela Gonsalves, Abrahams Ocanto, Eduardo Meilan, et al.
Lung Cancer (Amsterdam, Netherlands)|June 27, 2026
Limited predictive value of PD-L1 TPS for pathological response in NSCLC is not attributable to interobserver variabilityKonrad Steinestel, Lena-Maria Löwer-Kiem, Francesca Ambrosi, et al.
Expert Review of Anticancer Therapy|October 25, 2022
Evaluating new treatments for anaplastic thyroid cancerAndrés Coca-Pelaz, Juan P Rodrigo, Fernando Lopez, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2023
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriersRebeca Lozano, Elena Castro, Fernando Lopez-Campos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 21, 2018
Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung CancerYasushi Yatabe, Sanja Dacic, Alain C Borczuk, et al.
JTO Clinical and Research Reports|March 25, 2024
<i>RET</i> Fusion Testing in Patients With NSCLC: The RETING StudyEsther Conde, Susana Hernandez, Jose Luis Rodriguez Carrillo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 25, 2019
PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology CommitteeSylvie Lantuejoul, Ming Sound-Tsao, Wendy A Cooper, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 4, 2021
The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLCMari Mino-Kenudson, Nolwenn Le Stang, Jillian B Daigneault, et al.
Pageof 29

Showing results (261-270 of 285) with videos related to

Sort By:
Pageof 29
Advances in Therapy|March 15, 2023
Management of Older Patients with Head and Neck Cancer: A Comprehensive ReviewLeandro L Matos, Alvaro Sanabria, K Thomas Robbins, et al.
Archives of Pathology & Laboratory Medicine|September 12, 2019
Correlation of ROS1 Immunohistochemistry With <i>ROS1</i> Fusion Status Determined by Fluorescence In Situ HybridizationRichard S P Huang, Derek Smith, Catherine H Le, et al.
Biomedicines|October 29, 2025
First Spanish Experience with Stereotactic MR-Guided Adaptive Radiotherapy (SMART) in Borderline Resectable and Locally Advanced Pancreatic Cancer: A Prospective StudyDaniela Gonsalves, Abrahams Ocanto, Eduardo Meilan, et al.
Lung Cancer (Amsterdam, Netherlands)|June 27, 2026
Limited predictive value of PD-L1 TPS for pathological response in NSCLC is not attributable to interobserver variabilityKonrad Steinestel, Lena-Maria Löwer-Kiem, Francesca Ambrosi, et al.
Expert Review of Anticancer Therapy|October 25, 2022
Evaluating new treatments for anaplastic thyroid cancerAndrés Coca-Pelaz, Juan P Rodrigo, Fernando Lopez, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2023
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriersRebeca Lozano, Elena Castro, Fernando Lopez-Campos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 21, 2018
Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung CancerYasushi Yatabe, Sanja Dacic, Alain C Borczuk, et al.
JTO Clinical and Research Reports|March 25, 2024
<i>RET</i> Fusion Testing in Patients With NSCLC: The RETING StudyEsther Conde, Susana Hernandez, Jose Luis Rodriguez Carrillo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 25, 2019
PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology CommitteeSylvie Lantuejoul, Ming Sound-Tsao, Wendy A Cooper, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 4, 2021
The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLCMari Mino-Kenudson, Nolwenn Le Stang, Jillian B Daigneault, et al.
Pageof 29